Stanley Sugarman
Internal Medicine · Vancouver, WANPI 1497791230
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 379 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,657 and has fallen 99.2% since, to $22 in 2023. Among internal medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 379 payments — averaging $17.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$874
- AbbVie$810
- Amgen$735
- Novo Nordisk$561
- Johnson & Johnson$430
- AstraZeneca$430
- plus $3K from 30 others
What the payments were for
- Food & beverage$6,790100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 49 | $874 |
| AbbVie | 42 | $810 |
| Amgen | 33 | $735 |
| Novo Nordisk | 30 | $561 |
| Johnson & Johnson | 24 | $430 |
| AstraZeneca | 20 | $430 |
| Boehringer Ingelheim | 33 | $397 |
| Lilly USA, LLC | 19 | $381 |
| E.r. Squibb & Sons, L.L.C. | 22 | $331 |
| Sanofi-aventis U.S. LLC | 15 | $283 |
| Astellas Pharma US Inc | 10 | $188 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $139 |
| Amarin Pharma, Inc. | 7 | $131 |
| GSK | 6 | $109 |
| Boston Scientific | 6 | $97 |
| Novartis | 5 | $91 |
| Merck | 7 | $89 |
| Gilead | 4 | $86 |
| Biohaven Pharmaceuticals, Inc. | 5 | $64 |
| CMP Pharma, Inc. | 3 | $59 |
| Medtronic | 1 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $45 |
| Sanofi Pasteur Inc. | 3 | $44 |
| Bausch Health US, LLC | 2 | $42 |
| Abbott | 2 | $42 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Circassia Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Radius Health, Inc. | 2 | $28 |
| Bayer | 2 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,790 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.
Other internal medicine in Vancouver
- Nicholas CarulliVancouver$8K
- Katalin WolfordVancouver$6K
- Peter ShalitSeattle$1M
- Lawrence LoebBellevue$784K
- Shawna PurcellOlympia$294K
- Scott RamseySeattle$230K
- Michael CairnsSeattle$144K
- Peiqing QianSeattle$117K
- Alan KellySpokane Valley$96K
- Emily EgdaminWenatchee$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.